Thermo Fisher Scientific plans to acquire a Philadelphia-based clinical trial software company for $8.9 billion from a ...

Thermo Fisher Scientific plans to acquire a Philadelphia-based clinical trial software company for $8.9 billion.

Life sciences group Thermo Fisher has sealed an all-cash takeover of drug trial software maker Clario in a deal that values ...

Thermo Fisher ( NYSE: TMO) is nearing a takeover of Clario in an all-cash deal that could value the clinical trial data ...

Key opportunities in the clinical trial platform market include leveraging AI and machine learning for enhanced trial design ...

Suvoda (recently merged under common ownership with Greenphire), a global clinical trial technology company specializing in ...

As the world becomes more digital, clinical research is evolving. One major change is the rise of decentralized clinical ...

According to Mordor Intelligence, the global clinical trials market is valued at USD 90.1 billion in 2025 and is projected to ...

Key drivers of this growth include the increasing number of decentralized clinical trials, the rising adoption ...

The Suvoda app enables patients to complete questionnaires, schedule visits and submit receipts for reimbursement.

Clinical trials form the backbone of modern medicine, bridging the gap between laboratory discoveries and patient care. Yet, managing these trials has never been more complex. As the pharmaceutical ...